Boule Diagnostics AB (OSTO:BOUL) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:BOUL Boule Diagnostics AB OSTO:BOUL
40 GF Score
Price kr2.42
GF Value kr6.78
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Boule Diagnostics AB Net Loan?

Net Loan only applies to banks and insurance companies.

OSTO:BOUL
40GF Score
Boule Diagnostics AB OSTO:BOUL
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Boule Diagnostics AB (OSTO:BOUL) Overvalued in 2026?

Based on GuruFocus' analysis, Boule Diagnostics AB stock appears to be undervalued. The current stock price of kr2.42 is trading 64.3% below its estimated GF Value™ of kr6.78. GuruFocus considers Boule Diagnostics AB to be Possible Value Trap.

Key valuation signals for OSTO:BOUL:

  • Net Loan:
  • GF Value™: kr6.78 vs. price of kr2.42 (64.3% below fair value)
  • GF Score™: 40/100 with 4 warning signs

No single metric tells the full story. See the OSTO:BOUL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boule Diagnostics AB Business Description

Address Fagerstagatan 7, Spanga, SWE, SE-163 53
Boule Diagnostics AB is a Swedish medical diagnostics company that develops, manufactures, and markets instruments and consumables for blood cell counting and blood analysis. Its core offering consists of compact hematology analyzers and associated reagents, controls, and consumables used in point-of-care and small-laboratory settings. The company serves small and medium-sized hospitals, clinics, and outpatient laboratories, as well as larger diagnostic partners. Boule operates through two segments: Diagnostics, which supplies its own branded systems and reagents, and OEM CDS, which provides customized instrument and reagent solutions to other diagnostics companies. It sells through direct operations and distributors across Europe, the Americas, Asia, Africa, and the Middle East. Revenue is generated primarily through instrument sales and recurring consumable and reagent sales, with the recurring aftermarket business providing a significant and stable share of total revenue.
40GF Score

Get the complete analysis for OSTO:BOUL

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.42
Price
kr6.78
GF Value